How much is the Proton Pump Inhibitors (PPIs) Market market?

The proton pump inhibitors (ppis) market market size is estimated to grow at $$ 807.89 mn in 2023. Read More

What is the growth rate of the Proton Pump Inhibitors (PPIs) Market market?

The growth rate of the proton pump inhibitors (ppis) market year-over-year is 4.86%. Read More

Which region held the largest market share in the Proton Pump Inhibitors (PPIs) Market market?

North America is the region to held the largest market share with 36% growth. Read More

Who are the key players in the Proton Pump Inhibitors (PPIs) Market market?

Amgen Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Companies Inc., Bayer AG, Cipla Ltd., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Eli Lilly and .... Read More

Which Segment has the largest market share in the Proton Pump Inhibitors (PPIs) Market market?

Product is the segment that has the largest market share in the market. Read More

Proton Pump Inhibitors (PPIs) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Published: Nov 2023
Pages: 161
SKU: IRTNTR71850

Enjoy complimentary customisation on priority with our Enterprise License!

Proton Pump Inhibitors Market Size 2024-2028

The proton pump inhibitors (PPIs) market size is forecast to increase by USD 807.89 million at a CAGR of 4.86% between 2023 and 2028. The market is experiencing significant growth, driven by several key factors. Reformulation of drugs to address patient needs and improve therapeutic outcomes is a major growth catalyst. Additionally, the expanding geriatric population, which is more susceptible to gastroesophageal reflux disease and other conditions requiring PPIs, is fueling market expansion. However, the market also faces challenges, including increasing lawsuits against PPIs due to potential side effects. These legal actions may lead to regulatory scrutiny and increased costs for manufacturers. Despite these challenges, the market's growth prospects remain strong, driven by the unmet medical needs of an aging population and ongoing research and development efforts to improve PPI safety and efficacy.

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global proton pump inhibitors (PPIs) market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global proton pump inhibitors (ppis) market 2018 - 2022 ($ million)

4.2 Product Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Product Segment 2018 - 2022 ($ million)

4.3 Route of Administration Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Route of Administration Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Product - Market share 2023-2028 (%)

6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product

6.3 OTC PPIs - Market size and forecast 2023-2028
- Exhibit 34: Chart on OTC PPIs - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on OTC PPIs - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on OTC PPIs - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on OTC PPIs - Year-over-year growth 2023-2028 (%)

6.4 Prescription PPIs - Market size and forecast 2023-2028
- Exhibit 38: Chart on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Prescription PPIs - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Prescription PPIs - Year-over-year growth 2023-2028 (%)

6.5 Market opportunity by Product
- Exhibit 42: Market opportunity by Product ($ million)
- Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Route of Administration

7.1 Market segments
- Exhibit 44: Chart on Route of Administration - Market share 2023-2028 (%)
- Exhibit 45: Data Table on Route of Administration - Market share 2023-2028 (%)

7.2 Comparison by Route of Administration
- Exhibit 46: Chart on Comparison by Route of Administration
- Exhibit 47: Data Table on Comparison by Route of Administration

7.3 Oral - Market size and forecast 2023-2028
- Exhibit 48: Chart on Oral - Market size and forecast 2023-2028 ($ million)
- Exhibit 49: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
- Exhibit 50: Chart on Oral - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on Oral - Year-over-year growth 2023-2028 (%)

7.4 Injectable - Market size and forecast 2023-2028
- Exhibit 52: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Injectable - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Injectable - Year-over-year growth 2023-2028 (%)

7.5 Market opportunity by Route of Administration
- Exhibit 56: Market opportunity by Route of Administration ($ million)
- Exhibit 57: Data Table on Market opportunity by Route of Administration ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 59: Chart on Market share by geography 2023-2028 (%)
- Exhibit 60: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 61: Chart on Geographic comparison
- Exhibit 62: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Germany - Market size and forecast 2023-2028
- Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.9 China - Market size and forecast 2023-2028
- Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)

9.10 Canada - Market size and forecast 2023-2028
- Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.11 UK - Market size and forecast 2023-2028
- Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 99: Market opportunity by geography ($ million)
- Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 101: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 103: Overview on factors of disruption

11.4 Industry risks
- Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 105: Vendors covered

12.2 Market positioning of vendors
- Exhibit 106: Matrix on vendor position and classification

12.3 Amgen Inc.
- Exhibit 107: Amgen Inc. - Overview
- Exhibit 108: Amgen Inc. - Product / Service
- Exhibit 109: Amgen Inc. - Key offerings

12.4 AstraZeneca Plc
- Exhibit 110: AstraZeneca Plc - Overview
- Exhibit 111: AstraZeneca Plc - Product / Service
- Exhibit 112: AstraZeneca Plc - Key news
- Exhibit 113: AstraZeneca Plc - Key offerings

12.5 Aurobindo Pharma Ltd.
- Exhibit 114: Aurobindo Pharma Ltd. - Overview
- Exhibit 115: Aurobindo Pharma Ltd. - Product / Service
- Exhibit 116: Aurobindo Pharma Ltd. - Key offerings

12.6 Bausch Health Companies Inc.
- Exhibit 117: Bausch Health Companies Inc. - Overview
- Exhibit 118: Bausch Health Companies Inc. - Business segments
- Exhibit 119: Bausch Health Companies Inc. - Key news
- Exhibit 120: Bausch Health Companies Inc. - Key offerings
- Exhibit 121: Bausch Health Companies Inc. - Segment focus

12.7 Bayer AG
- Exhibit 122: Bayer AG - Overview
- Exhibit 123: Bayer AG - Business segments
- Exhibit 124: Bayer AG - Key news
- Exhibit 125: Bayer AG - Key offerings
- Exhibit 126: Bayer AG - Segment focus

12.8 Dr Reddys Laboratories Ltd.
- Exhibit 127: Dr Reddys Laboratories Ltd. - Overview
- Exhibit 128: Dr Reddys Laboratories Ltd. - Business segments
- Exhibit 129: Dr Reddys Laboratories Ltd. - Key offerings
- Exhibit 130: Dr Reddys Laboratories Ltd. - Segment focus

12.9 Eisai Co. Ltd.
- Exhibit 131: Eisai Co. Ltd. - Overview
- Exhibit 132: Eisai Co. Ltd. - Business segments
- Exhibit 133: Eisai Co. Ltd. - Key offerings
- Exhibit 134: Eisai Co. Ltd. - Segment focus

12.10 Eli Lilly and Co.
- Exhibit 135: Eli Lilly and Co. - Overview
- Exhibit 136: Eli Lilly and Co. - Product / Service
- Exhibit 137: Eli Lilly and Co. - Key news
- Exhibit 138: Eli Lilly and Co. - Key offerings

12.11 Glenmark Pharmaceuticals Ltd.
- Exhibit 139: Glenmark Pharmaceuticals Ltd. - Overview
- Exhibit 140: Glenmark Pharmaceuticals Ltd. - Product / Service
- Exhibit 141: Glenmark Pharmaceuticals Ltd. - Key offerings

12.12 Pfizer Inc.
- Exhibit 142: Pfizer Inc. - Overview
- Exhibit 143: Pfizer Inc. - Product / Service
- Exhibit 144: Pfizer Inc. - Key news
- Exhibit 145: Pfizer Inc. - Key offerings

12.13 Sun Pharmaceutical Industries Ltd.
- Exhibit 146: Sun Pharmaceutical Industries Ltd. - Overview
- Exhibit 147: Sun Pharmaceutical Industries Ltd. - Product / Service
- Exhibit 148: Sun Pharmaceutical Industries Ltd. - Key offerings

12.14 Takeda Pharmaceutical Co. Ltd.
- Exhibit 149: Takeda Pharmaceutical Co. Ltd. - Overview
- Exhibit 150: Takeda Pharmaceutical Co. Ltd. - Product / Service
- Exhibit 151: Takeda Pharmaceutical Co. Ltd. - Key news
- Exhibit 152: Takeda Pharmaceutical Co. Ltd. - Key offerings

12.15 Teva Pharmaceutical Industries Ltd.
- Exhibit 153: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 154: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 155: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 156: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 157: Teva Pharmaceutical Industries Ltd. - Segment focus

12.16 The Procter and Gamble Co.
- Exhibit 158: The Procter and Gamble Co. - Overview
- Exhibit 159: The Procter and Gamble Co. - Business segments
- Exhibit 160: The Procter and Gamble Co. - Key news
- Exhibit 161: The Procter and Gamble Co. - Key offerings
- Exhibit 162: The Procter and Gamble Co. - Segment focus

12.17 Zydus Lifesciences Ltd.
- Exhibit 163: Zydus Lifesciences Ltd. - Overview
- Exhibit 164: Zydus Lifesciences Ltd. - Business segments
- Exhibit 165: Zydus Lifesciences Ltd. - Key offerings
- Exhibit 166: Zydus Lifesciences Ltd. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 167: Inclusions checklist
- Exhibit 168: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 169: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 170: Research methodology
- Exhibit 171: Validation techniques employed for market sizing
- Exhibit 172: Information sources